The good news is that the SURMOUNT-5 trial found no statistically significant difference in GI side effect rates between the two medications at their respective therapeutic doses
Chia TY, Gan C-Y, Shafie MH, Yap PG, Mohd Rodhi A, Ahmad A, et al
Researched For 5-Amino-1MQ has been investigated as a selective inhibitor of nicotinamide N-methyltransferase, with studies examining how NNMT blockade affects cellular metabolism in preclinical models
This is applicable for all medications, including brand-name Ozempic and Wegovy, as well as generic Semaglutide
Common symptoms include: Nausea and vomiting , particularly after meals or in the morning Early satiety feeling full after eating only small amounts of food Abdominal bloating and distension , often worsening throughout the day Upper abdominal discomfort or pain Heartburn or acid reflux due to prolonged retention of stomach contents Loss of appetite and unintentional weight loss beyond expected therapeutic effects Fluctuating blood glucose levels , as unpredictable gastric emptying affects carbohydrate absorption For most patients on Ozempic, mild to moderate gastrointestinal symptoms are transient and manageable, typically occurring during the initial weeks of treatment or following dose increases